The ESCMID Study Group for Staphylococci and Staphylococcal Diseases (ESGS) focuses on the challenges posed by Staphylococcus aureus, one of the most frequent bacterial pathogens in both community and healthcare settings. With staphylococcal infections on the rise, ESGS is committed more than ever to understanding S. aureus complex pathogenesis and interactions with human hosts. Their common mission is focused on:
Niche specialization and spread of Staphylococcus capitis involved in neonatal sepsis.
Wirth T, Bergot M, Rasigade J-P, Pichon B, Barbier M, Martins-Simoes P, Jacob L, Pike R, Tissieres P, Picaud J-C, Kearns A, Supply P, Butin M, Laurent F, International Consortium for Staphylococcus capitis neonatal sepsis, ESGS Study Group of ESCMID. Nat Microbiol. 2020;5(5):735–745.
Implications of identifying the recently defined members of the Staphylococcus aureus complex S. argenteus and S. schweitzeri: a position paper of members of the ESCMID Study Group for Staphylococci and Staphylococcal Diseases (ESGS).
Becker K, Schaumburg F, Kearns A, Larsen AR, Lindsay JA, Skov RL, Westh H. Clin Microbiol Infect. 2019;25(9):1064–1070.
ESGS webinar - Staphylococcus aureus: Probiotics and decolonisation; GWAS and AI
Staphylococcus aureus: Platelets and the SNAP trial
Staphylococcus aureus: Cell-intrinsic immunity to staphylococcal α-toxin and adjunctive agents
If you have questions or comments for our study group, we warmly invite you to contact us!